White Paper

Significant Change Within the Context on EU MDR


Regulatory Affairs



Medical Devices
< Back to Insights


During the lifecycle of a device, changes are inevitable. These changes can occur for several reasons, some of which may be unexpected such as a sudden supply chain disruption, material shortage, etc. Significant change is cited twice in EU MDR 2017/745. The focus of this white paper is to delve into significant changes and what changes could jeopardize valid Directive 93/42/EEC (MDD) or 90/385/EEC (AIMDD) certs for legacy devices leading to the necessity of applying for a MDR cert prior to the end of the transition period as set by the European Union Law. This paper provides an overview summary of the recently updated guidance Medical Device Coordination Group (MDCG) document 2020-3 Rev 1 titled, Guidance on significant changes regarding the transitional provision under Article 120 of the MDR with regard to devices covered by certificates according to MDD or AIMDD.

Download White Paper

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

We're Here to Help

When you engage ECI, you can focus on your business. Let us focus on the momentum of the industry and help you keep pace across your portfolio.

Contact US